Mae O Gordon

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma
    Mae O Gordon
    OHTS Coordinating Center, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Box 8203, 660 South Euclid, St Louis, MO 63110, USA
    Arch Ophthalmol 120:714-20; discussion 829-30. 2002
  2. ncbi Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension
    Mae O Gordon
    OHTS Coordinating Center, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Box 8203, 660 South Euclid, St Louis, MO 63110, USA
    Ophthalmology 114:10-9. 2007
  3. ncbi The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
    Michael A Kass
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Arch Ophthalmol 120:701-13; discussion 829-30. 2002
  4. ncbi Delaying treatment of ocular hypertension: the ocular hypertension treatment study
    Michael A Kass
    Ocular Hypertension Treatment Study Coordinating Center, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Box 8203, 660 S Euclid Ave, St Louis, MO 63110, USA
    Arch Ophthalmol 128:276-87. 2010
  5. ncbi The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110 1093, USA
    Ophthalmology 119:1367-74. 2012
  6. ncbi Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Campus Box 8096, 660 S Euclid Ave, St Louis, MO 63110 1093, USA
    Arch Ophthalmol 128:613-8. 2010
  7. ncbi The utility of the monocular trial: data from the ocular hypertension treatment study
    Anjali M Bhorade
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri, USA
    Ophthalmology 117:2047-54. 2010
  8. ncbi Changes in the quality-of-life of people with keratoconus
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Ophthalmol 145:611-617. 2008
  9. ncbi The incidence of retinal vein occlusion in the ocular hypertension treatment study
    Edward M Barnett
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Ophthalmology 117:484-8. 2010
  10. ncbi Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Ophthalmol 141:997-1008. 2006

Research Grants

  1. EGPS/OHTS Collaborative Analysis
    MAE GORDON; Fiscal Year: 2005
  2. CLEK-COORDINATING CENTER
    MAE GORDON; Fiscal Year: 2004
  3. Ocular Hypertension Treatment Study: Coordinating Center
    MAE GORDON; Fiscal Year: 2007

Detail Information

Publications42

  1. ncbi The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma
    Mae O Gordon
    OHTS Coordinating Center, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Box 8203, 660 South Euclid, St Louis, MO 63110, USA
    Arch Ophthalmol 120:714-20; discussion 829-30. 2002
    ....
  2. ncbi Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension
    Mae O Gordon
    OHTS Coordinating Center, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Box 8203, 660 South Euclid, St Louis, MO 63110, USA
    Ophthalmology 114:10-9. 2007
    ....
  3. ncbi The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
    Michael A Kass
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Arch Ophthalmol 120:701-13; discussion 829-30. 2002
    ....
  4. ncbi Delaying treatment of ocular hypertension: the ocular hypertension treatment study
    Michael A Kass
    Ocular Hypertension Treatment Study Coordinating Center, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Box 8203, 660 S Euclid Ave, St Louis, MO 63110, USA
    Arch Ophthalmol 128:276-87. 2010
    ..To compare the safety and efficacy of earlier vs later treatment in preventing primary open-angle glaucoma (POAG) in individuals with ocular hypertension...
  5. ncbi The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110 1093, USA
    Ophthalmology 119:1367-74. 2012
    ..To create and validate a statistical model predicting progression of primary open-angle glaucoma (POAG) assessed by loss of visual field as measured in mean deviation (MD) using 3 landmark studies of glaucoma progression and treatment...
  6. ncbi Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Campus Box 8096, 660 S Euclid Ave, St Louis, MO 63110 1093, USA
    Arch Ophthalmol 128:613-8. 2010
    ..To assess the influence of expected life span on the cost-effectiveness of treating ocular hypertension to prevent primary open-angle glaucoma...
  7. ncbi The utility of the monocular trial: data from the ocular hypertension treatment study
    Anjali M Bhorade
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri, USA
    Ophthalmology 117:2047-54. 2010
    ..To determine whether adjusting the intraocular pressure (IOP) change of the trial eye for the IOP change of the fellow eye (i.e., monocular trial) is a better assessment of medication response than testing each eye independently...
  8. ncbi Changes in the quality-of-life of people with keratoconus
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Ophthalmol 145:611-617. 2008
    ..For this study, we evaluated changes that occurred in V-QoL over seven years of follow-up...
  9. ncbi The incidence of retinal vein occlusion in the ocular hypertension treatment study
    Edward M Barnett
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Ophthalmology 117:484-8. 2010
    ..To determine the incidence of retinal vein occlusion (RVO) in the Ocular Hypertension Treatment Study (OHTS)...
  10. ncbi Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study
    Steven M Kymes
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Ophthalmol 141:997-1008. 2006
    ..There is no consensus on which people with ocular hypertension would benefit from treatment...
  11. ncbi The lifetime economic burden of keratoconus: a decision analysis using a markov model
    Ronald L Rebenitsch
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110 1093, USA
    Am J Ophthalmol 151:768-773.e2. 2011
    ..To estimate the expected incremental lifetime cost of treatment of keratoconus compared to the expected cost of the treatment of myopia...
  12. ncbi The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis
    Feng Gao
    Division of Biostatistics, Washington University School of Medicine, St, Louis, MO, 63110, USA
    BMC Med Res Methodol 12:151. 2012
    ..abstract:..
  13. ncbi Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study
    Anjali M Bhorade
    Washington University School of Medicine, St Louis, Missouri 63110, USA
    Ophthalmology 116:717-24. 2009
    ..To describe variability of intraocular pressure (IOP) measurements within the same eye and between right and left eyes over a 60-month period in participants in the Ocular Hypertension Treatment Study...
  14. ncbi Baseline factors predictive of incident penetrating keratoplasty in keratoconus
    Mae O Gordon
    Division of Biostatistics and the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri, USA
    Am J Ophthalmol 142:923-30. 2006
    ..Knowledge of these factors is beneficial to clinicians in patient education and may be useful in disease management...
  15. ncbi Effect of measurement order between right and left eyes on intraocular pressure measurement
    Melike Pekmezci
    Department of Ophthalmology, University of California, San Francisco, USA
    Arch Ophthalmol 129:276-81. 2011
    ..To determine whether the order of intraocular pressure (IOP) measurement between right and left eyes affects IOP measurement...
  16. ncbi The impact of anchor point on utilities for 5 common ophthalmic diseases
    Bryan S Lee
    Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Ophthalmology 115:898-903.e4. 2008
    ..To elicit utilities on a perfect health and perfect vision scale for 5 common eye diseases...
  17. ncbi Quality of life in keratoconus
    Steven M Kymes
    Washington University School of Medicine, St Louis, Missouri 63110 1093, USA
    Am J Ophthalmol 138:527-35. 2004
    ..We examined the vision-related quality of life of patients in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study...
  18. ncbi Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study
    Steven L Mansberger
    Devers Eye Institute Discoveries In Sight, Legacy Health System, Portland, Ore, USA
    Arch Ophthalmol 125:454-9. 2007
    ....
  19. ncbi Visual field quality control in the Ocular Hypertension Treatment Study (OHTS)
    John L Keltner
    Department of Ophthalmology and Vision Science, University of California, Davis, CA, USA
    J Glaucoma 16:665-9. 2007
    ....
  20. ncbi Changes in central corneal thickness over time: the ocular hypertension treatment study
    James D Brandt
    Department of Ophthalmology and Vision Science, University of California, Sacramento, California, USA
    Ophthalmology 115:1550-6, 1556.e1. 2008
    ....
  21. ncbi Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study
    Linda M Zangwill
    Department of Ophthalmology, University of California, San Diego, La Jolla 92093, USA
    Arch Ophthalmol 122:22-8. 2004
    ..To examine racial differences in optic disc topography among ocular hypertensive participants in the Ocular Hypertension Treatment Study...
  22. ncbi Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study
    David C Herman
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Ophthalmol 142:800-10. 2006
    ..We found no evidence for a general effect of topical ocular hypotensive medication on lens opacification or visual function...
  23. ncbi Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study
    Donald L Budenz
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Ophthalmology 113:2137-43. 2006
    ....
  24. ncbi The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study
    John L Keltner
    Department of Ophthalmology and Visual Science, University of California, Davis, Sacramento, California 95817, USA
    Ophthalmology 113:1603-12. 2006
    ..To determine the association between change from baseline in the optic nerve head (ONH) and the visual field (VF) during follow-up of ocular hypertension participants in the Ocular Hypertension Treatment Study...
  25. ncbi Baseline visual field characteristics in the ocular hypertension treatment study
    Chris A Johnson
    Discoveries in Sight, Devers Eye Institute, Portland, Oregon
    Ophthalmology 109:432-7. 2002
    ..A clinical screening review of otherwise normal and reliable tests was not restrictive. The adoption of a 33% fixation loss cutoff significantly reduced the number of required retests and prevented study rejection of 89 patients...
  26. ncbi Classification of visual field abnormalities in the ocular hypertension treatment study
    John L Keltner
    Visual Field Reading Center, Department of Ophthalmology, University of California Davis, Sacramento, 95817, USA
    Arch Ophthalmol 121:643-50. 2003
    ..1) To develop a classification system for visual field (VF) abnormalities, (2) to determine interreader and test-retest agreement, and (3) to determine the frequency of various VF defects in the Ocular Hypertension Treatment Study...
  27. ncbi The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors
    Linda M Zangwill
    Department of Ophthalmology, University of California at San Diego, La Jolla, California 92093 0946, USA
    Am J Ophthalmol 137:219-27. 2004
    ....
  28. ncbi Variables affecting rigid contact lens comfort in the collaborative longitudinal evaluation of keratoconus (CLEK) study
    Timothy B Edrington
    Optom Vis Sci 81:182-8. 2004
    ..To identify factors associated with rigid contact lens comfort in keratoconus...
  29. ncbi The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals
    Eve J Higginbotham
    Department of Ophthalmology, Maryland Center for Eye Care Associates, Baltimore, USA
    Arch Ophthalmol 122:813-20. 2004
    ..50; 95% confidence interval, 0.28-0.90; P =.02). CONCLUSION: Topical ocular hypotensive therapy is effective in delaying or preventing the onset of POAG in African American individuals who have ocular hypertension...
  30. ncbi Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study
    Anne L Coleman
    Jules Stein Eye Institute, University of California, Los Angeles, USA
    Am J Ophthalmol 138:684-5. 2004
    ..CONCLUSION: Whether PSD or VC/D was included in the Cox proportional hazards model, the same baseline factors were statistically significant and their hazard ratios were essentially similar...
  31. ncbi Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study
    James D Brandt
    Department of Ophthalmology, University of California, Davis, Sacramento, California, USA
    Am J Ophthalmol 138:717-22. 2004
    ..We believe that CCT measurements may be useful in patient management and in interpreting clinical trials of ocular hypotensive medication...
  32. ncbi Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice
    Michael A Kass
    Arch Ophthalmol 123:1021-2. 2005
  33. ncbi The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center
    William J Feuer
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida 33136, USA
    Am J Ophthalmol 133:19-28. 2002
    ..Horizontal cup/disk ratio measurements in OHTS are sufficiently reproducible to provide information about the relationship of cup/disk ratio to the prognosis of individuals with ocular hypertension...
  34. ncbi Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study
    Linda M Zangwill
    Hamilton Glaucoma Center and Diagnostic Imaging Laboratory, Department of Ophthalmology, University of California San Diego, La Jolla, CA 92093, USA
    Arch Ophthalmol 123:1188-97. 2005
    ..To determine whether baseline confocal scanning laser ophthalmoscopy (CSLO) optic disc topographic measurements are associated with the development of primary open-angle glaucoma (POAG) in individuals with ocular hypertension...
  35. ncbi Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study
    John L Keltner
    Visual Field Reading Center, Department of Ophthalmology, University of California Davis, 4860 Y Street, Ste 2400, Sacramento, CA 95817, USA
    Arch Ophthalmol 123:1201-6. 2005
    ..To compare the occurrence of normal visual field (VF) test results following 2 vs 3 consecutive, abnormal, reliable test results in the Ocular Hypertension Treatment Study...
  36. ncbi Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders
    Richard K Parrish
    Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Am J Ophthalmol 140:762-4. 2005
    ..Consistency (specificity) in re-grading optic disks that did not develop deterioration was particularly high. The sensitivity results show that detecting subtle deterioration of optic disks is challenging...
  37. ncbi Comparison of flat and steep rigid contact lens fitting methods in keratoconus
    Karla Zadnik
    The Ohio State University College of Optometry, Columbus, 43210, USA
    Optom Vis Sci 82:1014-21. 2005
    ..The purpose of this article is to compare the safety and efficacy of flat- and steep-fitting rigid contact lenses in keratoconus...
  38. ncbi Longitudinal changes in visual acuity in keratoconus
    Larry J Davis
    University of Missouri-St. Louis College of Optometry, St. Louis, Missouri, USA
    Invest Ophthalmol Vis Sci 47:489-500. 2006
    ..Better baseline BCVA, steeper FDACL, and fundus abnormalities were predictive of greater acuity loss with time...
  39. ncbi Differences in keratoconus as a function of gender
    Barbara A Fink
    The Ohio State University College of Optometry, 338 West Tenth Avenue, Columbus OH 43210-1240, USA
    Am J Ophthalmol 140:459-68. 2005
    ..NEI-VFQ results revealed differences in self-reported difficulty with distance activities and driving. CONCLUSIONS: Gender differences exist in patient history, vision, and ocular symptoms in keratoconus patients...
  40. ncbi Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?
    Mae O Gordon
    Arch Ophthalmol 126:280-1. 2008
  41. ncbi Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study
    Joseph T Barr
    Ohio State University College of Optometry, 338 West Tenth Avenue, Columbus, 43210-1240, USA
    Cornea 25:16-25. 2006
    ..These findings suggest a causal contribution of contact lens wear to corneal scarring in keratoconus and imply that corneal scarring might be reduced by modifying the contact lens fit...
  42. ncbi Diabetes and glaucoma
    Michael A Kass
    Arch Ophthalmol 126:746-7. 2008

Research Grants6

  1. EGPS/OHTS Collaborative Analysis
    MAE GORDON; Fiscal Year: 2005
    ..A Joint Committee will be responsible for implementing the study, overseeing the analyses and preparing presentations and publications. ..
  2. CLEK-COORDINATING CENTER
    MAE GORDON; Fiscal Year: 2004
    ..The DCC is responsible for the study design, management of study data, monitoring the performance of the Reading Center and participating clinics, preparation of performance reports, analysis of data and presentation of results. ..
  3. Ocular Hypertension Treatment Study: Coordinating Center
    MAE GORDON; Fiscal Year: 2007
    ..Developing plans for the orderly close-out of the study including participants, clinics, and resource centers 9. Archiving and documenting study data. ..